Briefing #1 of 1

CROX briefing — Crocs, Inc.

Released: 2026-04-27 Briefing series: #1 of N Prior briefing: first in series Stock at release: $103.39 Inflection pattern: distressed_recovery

What changed since the last briefing

(This is the first briefing in the series.)

Company snapshot

Ticker: CROX
Name: Crocs, Inc.
What they do: Crocs designs, develops, manufactures, and sells casual footwear under two brands: the Crocs Brand (the original clog and sandal line) and HEYDUDE (a soft-structured casual shoe brand acquired in 2022). Crocs Brand products are sold globally across DTC, wholesale, and digital channels; HEYDUDE is primarily a U.S. market brand distributed through wholesale and DTC. Both brands are manufactured primarily in Vietnam. (10-K FY2025, filed 2026-02-12)
IPO date: Listed on NASDAQ in 2006; first candle in data: 2021-04-28
Market cap at release: ~$5.6B (~54.2M weighted average diluted shares × $103.39)
Sector / Industry: Consumer Discretionary / Footwear
HQ: Broomfield, Colorado
CEO / Founder status: Mr. Andrew Rees (professional management) — professional management. (10-K FY2025, filed 2026-02-12)
Profitable?: No in FY2025 — net loss -$81.2M due to $738.1M in goodwill and asset impairments on the HEYDUDE segment. Operating income ex-impairments was $887.6M (22.0% margin). Cash from operations $710.4M. FY2024 net income was $950.1M. (10-K FY2025, filed 2026-02-12)
Total shares outstanding: ~54.2M basic weighted average (FY2025); ~57M shares outstanding (approximate; company has been repurchasing aggressively)
Fiscal year end: December

The arc

| Date | Event | Source | |------|-------|--------| | 2026-04-23 | Q1 2026 earnings preview coverage; stock -3.2% ahead of April 30 report | Event data, 2026-04-23 | | 2026-04-21 | Stock -5.7% — slide on weak consumer sentiment and tariff concern | Event data, 2026-04-21 | | 2026-04-22 | Continued sell-off; stock -3.5% | Event data, 2026-04-22 | | 2026-04-09 | "Cash machine" thesis article; stock +2.3% | Event data, 2026-04-09 | | 2026-04-08 | Value stock coverage; stock +9.6% | Event data, 2026-04-08 | | 2026-04-06 | Undervaluation thesis; stock +7.6% | Event data, 2026-04-06 | | 2026-03-23 | Value stock re-rating; stock +4.8% | Event data, 2026-03-23 | | 2026-03-10 | Wedbush initiated Neutral coverage; stock -7.5% | Wedbush / event data, 2026-03-10 | | 2026-02-12 | Filed 10-K FY2025: revenue $4,040.6M (▼1.5%), net loss -$81.2M on $738.1M HEYDUDE impairments; cash from operations $710.4M. $577.2M share repurchase in FY2025. | 10-K FY2025, filed 2026-02-12 | | 2025-10-01 | Q3 2025 results — most recent 10-Q period; quarterly HEYDUDE weakness persisting | 10-Q Q3 2025, filed 2025-10-30 | | 2025-06-01 | Q2 2025 triggering event: HEYDUDE goodwill impairment test triggered by weak U.S. consumer conditions and outsized tariff impact on HEYDUDE's sourcing model (primary Vietnam exposure). Goodwill impairment of $307.0M recognized. Additional asset impairments of $431.1M recognized — total $738.1M. | 10-K FY2025, filed 2026-02-12 | | 2022-02-01 | Acquired HEYDUDE for approximately $2.5B — the defining capital allocation decision of the post-IPO era. HEYDUDE revenue peaked and then began declining as consumer softness hit the brand disproportionately. | Industry reference / 10-K FY2025 (HEYDUDE background) |

Current state

Year-over-year changes (FY2024 → FY2025)

| Metric | FY2023 | FY2024 | FY2025 | Change FY24→FY25 | |--------|--------|--------|--------|-----------------| | Revenue ($M) | 3,962.3 | 4,102.1 | 4,040.6 | ▼1.5% | | Gross margin (%) | 55.8 | 58.8 | 58.3 | [DATA NEEDED] | | Operating income ($M, reported) | 1,036.8 | ~1,500 (implied from net income $950.1M) | 149.5 | [significant decline] | | Net income / (loss) ($M) | 792.6 | 950.1 | -81.2 | swing to loss | | Cash from operations ($M) | 930.4 | 992.5 | 710.4 | ▼28% |Source: 10-K FY2025, filed 2026-02-12. FY2023 revenue and prior gross margins require 10-K FY2023 review. The FY2025 net loss is entirely attributable to $738.1M in non-cash HEYDUDE impairments; cash generation remained positive.

FY2025 revenue of $4,040.6M declined 1.5% from $4,102.1M in FY2024. Revenue by segment and brand is not separately broken down in available summary data, but the 10-K narrative indicates the decline was concentrated in HEYDUDE, while the Crocs Brand remained comparatively healthy. SG&A grew $105.1M (8%) to $1,469.4M, primarily reflecting brand investment and distribution costs. (10-K FY2025, filed 2026-02-12.)

The defining FY2025 event was the Q2 2025 triggering event for HEYDUDE impairment testing. Weak U.S. consumer conditions and what the 10-K describes as the "outsized tariff impact" on HEYDUDE's sourcing model — HEYDUDE sources primarily from Vietnam and was in the process of shifting manufacturing away from China — led to a goodwill impairment of $307.0M and additional asset impairments of $431.1M on the HEYDUDE segment, totaling $738.1M. These non-cash charges converted an otherwise operationally profitable year into a reported net loss of -$81.2M. (10-K FY2025, filed 2026-02-12.)

Cash from operations of $710.4M (down from $992.5M in FY2024) reflects the underlying business's strong cash generation despite the headline net loss. The company repurchased $577.2M of stock (approximately 6.5M shares) in FY2025, aggressively returning capital while HEYDUDE was impaired. As of year-end 2025: cash $130.4M, long-term debt $1,230.9M, remaining repurchase authorization $746.8M. (10-K FY2025, filed 2026-02-12.)

Residual intangible assets were $1,324.7M and post-impairment goodwill was $404.7M (reduced from $711.5M at year-end 2024). These residual intangibles primarily represent the HEYDUDE brand value that survived impairment testing. (10-K FY2025, filed 2026-02-12.)

Q1 2026 results are scheduled for April 30, 2026 — not yet available. (Event data, 2026-04-23.)

Key numbers

| Metric | FY2022 | FY2023 | FY2024 | FY2025 | |--------|--------|--------|--------|--------| | Revenue ($M) | 3,555.0 | 3,962.3 | 4,102.1 | 4,040.6 | | Gross margin (%) | 52.3 | 55.8 | 58.8 | 58.3 | | Operating margin (%, reported) | 23.9 | 26.2 | 24.9 | 3.7 | | Operating margin (%, ex-impairments) | 23.9 | 26.2 | 24.9 | 22.0 | | Net income / (loss) ($M) | 540.2 | 792.6 | 950.1 | -81.2 | | Cash from operations ($M) | 191.6 | 149.3 | 992.5 | 710.4 |Source: 10-K FY2025, filed 2026-02-12. FY2022–FY2023 revenue and FY2024 gross margin require prior 10-K review.

Recent news (last 6 months)

| Date | Headline | Source | Market reaction | |------|----------|--------|-----------------| | 2026-04-23 | Q1 2026 earnings preview (report April 30) | Multiple | -3.2% | | 2026-04-22 | Continued sell-off on tariff/consumer concerns | Multiple | -3.5% | | 2026-04-21 | Slides on weak consumer sentiment | Multiple | -5.7% | | 2026-04-09 | "Cash machine" thesis coverage | Event data | +2.3% | | 2026-04-08 | Value stock coverage | Event data | +9.6% | | 2026-04-06 | Undervaluation thesis | Event data | +7.6% | | 2026-03-23 | Value stock re-rating | Event data | +4.8% | | 2026-03-10 | Wedbush initiates Neutral — cautious on HEYDUDE recovery | Wedbush | -7.5% | | 2026-02-12 | 10-K FY2025 filed: HEYDUDE impairments disclosed; $577.2M share buybacks | SEC EDGAR | [DATA NEEDED] |

Open questions

HEYDUDE stabilization: HEYDUDE triggered a $738.1M impairment in Q2 2025. Is FY2026 showing stabilization or continued decline? The Q1 2026 earnings (April 30, 2026) will be the first data point. Verify HEYDUDE revenue trend, gross margin recovery, and whether any additional impairment risk exists on residual goodwill of $404.7M and intangibles of $1,324.7M. (10-K FY2025, filed 2026-02-12.)
Tariff exposure quantification: The 10-K describes the "outsized tariff impact" on HEYDUDE as a triggering factor for impairment. HEYDUDE sources from Vietnam; Vietnam-manufactured goods face different tariff treatment than China-sourced goods under current U.S. trade framework. Quantify: what is the tariff rate increase on HEYDUDE's Vietnam sourcing, and what mitigation (price increases, cost reductions, re-sourcing) is planned? (10-K FY2025, filed 2026-02-12.)
Crocs Brand growth trajectory: The Crocs Brand appears to have remained healthy while HEYDUDE faltered. What were Crocs Brand revenue and margin for FY2025 separately from HEYDUDE? Segment-level P&L disclosure is required (typically available in 10-K Notes). Verify geographic breakdown: international Crocs vs. domestic HEYDUDE divergence.
CEO name and management structure: The CEO name was not captured in available filing summary data. Verify from 10-K cover page or DEF 14A proxy. Any management change related to HEYDUDE's performance warrants disclosure.
Share repurchase sustainability: $577.2M in buybacks against $130.4M in year-end cash means repurchases were funded largely from operating cash flow ($710.4M). $746.8M of authorization remains. Can CROX sustain this pace in 2026 given $1,230.9M in long-term debt and uncertainty around HEYDUDE recovery? Debt covenant restrictions are not available in summary data.

Red flags / things to verify

Residual HEYDUDE impairment risk: $404.7M in goodwill and $1,324.7M in intangibles remain on the balance sheet after the $738.1M write-down. Any further deterioration in HEYDUDE revenue, margin, or brand value could trigger additional impairments in FY2026, producing another reported net loss despite positive cash generation. (10-K FY2025, filed 2026-02-12.)
HEYDUDE acquisition judgment: Crocs acquired HEYDUDE for approximately $2.5B in February 2022. The combined impairments of $738.1M in one year represent a partial reversal of that acquisition's value. The long-term strategic rationale — brand diversification and TAM expansion — must be evaluated against realized impairment losses. If HEYDUDE revenue continues declining, the market may mark it as a capital allocation mistake.
Tariff risk on Vietnam sourcing: Both Crocs Brand and HEYDUDE source primarily from Vietnam. The 2025 tariff environment specifically cited Vietnam sourcing as increasing cost pressure on HEYDUDE. An escalation of tariffs on Vietnam-origin goods would materially affect both brands' COGS and gross margin.
High SG&A base: SG&A of $1,469.4M represented 36.4% of FY2025 revenue — a large fixed-cost base relative to a brand-oriented consumer company. As revenue declined 1.5%, SG&A grew 8%. If HEYDUDE continues to drag top-line growth, SG&A leverage moves unfavorably and compresses the ex-impairment operating margin below 22%.
Q1 2026 results pending April 30: As of briefing date (April 30 is three days away), Q1 2026 results are not yet available. The stock declined -12.4% combined over April 21–23, 2026, suggesting the market is pricing in deterioration in Q1 or a weak forward guide. The April 30 print is the first test of HEYDUDE recovery and will determine whether the distressed_recovery thesis is on track.

Sources

10-K (FY2025): Filed 2026-02-12 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=CROX&type=10-K&dateb=&owner=include&count=10
10-K (FY2024): Filed 2025-02-13 — SEC EDGAR
10-Q (Q3 2025, most recent): Filed 2025-10-30 — SEC EDGAR
10-Q (Q2 2025): Filed 2025-08-07 — SEC EDGAR
DEF 14A (Proxy Statement FY2025): Filed 2026-04-XX — SEC EDGAR
8-K (Q3 2025 earnings): Filed 2025-10-30 (approx.) — SEC EDGAR